Phocas Financial’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NRIX
BBA
Phocas Financial's NRIX Position: Q3 2026 in Review
Phocas Financial sold out of Nurix Therapeutics (NRIX) in Q3 2026, closing a stake of 99,589 shares — an estimated $2.42M sold.
Phocas Financial first reported a position in NRIX in Q2 2026 and held it in 1 quarter. The position peaked at $2.42M in Q2 2026. 233 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.
- Phocas Financial reported no remaining Nurix Therapeutics position as of Q3 2026 after selling out during the quarter.
- Phocas Financial sold 99,589 Nurix Therapeutics shares in Q3 2026, an estimated $2.42M.
- Phocas Financial first reported a position in Nurix Therapeutics in Q2 2026 and held it in 1 quarter.
- Phocas Financial's Nurix Therapeutics position peaked at $2.42M in Q2 2026.
- 233 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.
Based on Phocas Financial's 13F filing for Q3 2026.